Greece’s Thessaloniki Film Festival ends this evening with a screening of The End, the latest feature project from the ...
Oppenheimer upgrades MoneyLion to Outperform as it benefits from lower interest rates, easing regulations, and potential ...
Murphy tells IndieWire about playing a man who, in 1985, unearths awful discoveries at the local Irish convent — something ...
Oppenheimer has become the latest Wall Street firm to raise its year-end price target for the S&P 500. Chief Market Strategist John Stoltzfus said in a report shared with MarketWatch on Monday that ...
Oppenheimer AM lifted its 2024 year-end price target for the S&P 500 from 5,900 to 6,200. This marks the third time this year ...
Anand Mahindra, Chairman of the Mahindra Group in a post on social media encouraged making “rational decisions guided by ...
Oppenheimer analyst Colin Rusch maintained a Hold rating on Bloom Energy (BE – Research Report) today. The company’s shares closed yesterday at $10.67. Rusch covers the Technology sector, focusing on ...
Oppenheimer analysts provided some “color for Fundamental focus calls” to five buy-rated stocks in an uptrend.
Oppenheimer analyst Matthew Biegler maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report) today and set a price ...
Cillian Murphy didn’t read “Small Things Like These” looking for a film to do. He was simply a fan of the author, Claire ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.41% of ...